GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...
The Global Topical Drug Delivery Market Size is projected to grow at a CAGR of 6.3% from 2024 to 2031, according to a new report published by Verified Market Research ®. The report reveals that the ...
Cardiovascular disease remains the foremost cause of morbidity and mortality globally, affecting millions of individuals. Recent discoveries illuminate the substantial role of genetics in ...
The auto-injector market is projected to grow at a CAGR of 8.2% from 2023 to 2033, underscoring the rising demand for these ...
With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...
A recent study has developed a new molecular classification for gastrointestinal stromal tumours through multi-omics analysis, uncovering four distinct subtypes and identifying a potential tumour ...